BCL2L1 and melanoma: On the other hand, BIRC5, IGFR1, MCL1, BRAF, BCL2A1, BCL2L10, BCL2L1, and BCL2 were downregulated following UA treatment in A-375 melanoma cells (p < 0.05) (Figure 2d).